The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
Emek Kocatürk(Koç University), Marcus Maurer(Charité - Universitätsmedizin Berlin)
Cited by 89
Related Papers
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
|Theranostics|2017|135
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
|Allergy Asthma and Immunology Research|2021|102